Cargando…
Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage
Gene transfer allows transient or permanent genetic modifications of cells for experimental or therapeutic purposes. Gene delivery by HIV-derived lentiviral vector (LV) is highly effective but the risk of insertional mutagenesis is important and the random/uncontrollable integration of the DNA vecto...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067480/ https://www.ncbi.nlm.nih.gov/pubmed/24956106 http://dx.doi.org/10.1371/journal.pone.0099649 |
_version_ | 1782322299510194176 |
---|---|
author | Grandchamp, Nicolas Altémir, Dorothée Philippe, Stéphanie Ursulet, Suzanna Pilet, Héloïse Serre, Marie-Claude Lenain, Aude Serguera, Che Mallet, Jacques Sarkis, Chamsy |
author_facet | Grandchamp, Nicolas Altémir, Dorothée Philippe, Stéphanie Ursulet, Suzanna Pilet, Héloïse Serre, Marie-Claude Lenain, Aude Serguera, Che Mallet, Jacques Sarkis, Chamsy |
author_sort | Grandchamp, Nicolas |
collection | PubMed |
description | Gene transfer allows transient or permanent genetic modifications of cells for experimental or therapeutic purposes. Gene delivery by HIV-derived lentiviral vector (LV) is highly effective but the risk of insertional mutagenesis is important and the random/uncontrollable integration of the DNA vector can deregulate the cell transcriptional activity. Non Integrative Lentiviral Vectors (NILVs) solve this issue in non-dividing cells, but they do not allow long term expression in dividing cells. In this context, obtaining stable expression while avoiding the problems inherent to unpredictable DNA vector integration requires the ability to control the integration site. One possibility is to use the integrase of phage phiC31 (phiC31-int) which catalyzes efficient site-specific recombination between the attP site in the phage genome and the chromosomal attB site of its Streptomyces host. Previous studies showed that phiC31-int is active in many eukaryotic cells, such as murine or human cells, and directs the integration of a DNA substrate into pseudo attP sites (pattP) which are homologous to the native attP site. In this study, we combined the efficiency of NILV for gene delivery and the specificity of phiC31-int for DNA substrate integration to engineer a hybrid tool for gene transfer with the aim of allowing long term expression in dividing and non-dividing cells preventing genotoxicity. We demonstrated the feasibility to target NILV integration in human and murine pattP sites with a dual NILV vectors system: one which delivers phiC31-int, the other which constitute the substrate containing an attB site in its DNA sequence. These promising results are however alleviated by the occurrence of significant DNA damages. Further improvements are thus required to prevent chromosomal rearrangements for a therapeutic use of the system. However, its use as a tool for experimental applications such as transgenesis is already applicable. |
format | Online Article Text |
id | pubmed-4067480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40674802014-06-25 Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage Grandchamp, Nicolas Altémir, Dorothée Philippe, Stéphanie Ursulet, Suzanna Pilet, Héloïse Serre, Marie-Claude Lenain, Aude Serguera, Che Mallet, Jacques Sarkis, Chamsy PLoS One Research Article Gene transfer allows transient or permanent genetic modifications of cells for experimental or therapeutic purposes. Gene delivery by HIV-derived lentiviral vector (LV) is highly effective but the risk of insertional mutagenesis is important and the random/uncontrollable integration of the DNA vector can deregulate the cell transcriptional activity. Non Integrative Lentiviral Vectors (NILVs) solve this issue in non-dividing cells, but they do not allow long term expression in dividing cells. In this context, obtaining stable expression while avoiding the problems inherent to unpredictable DNA vector integration requires the ability to control the integration site. One possibility is to use the integrase of phage phiC31 (phiC31-int) which catalyzes efficient site-specific recombination between the attP site in the phage genome and the chromosomal attB site of its Streptomyces host. Previous studies showed that phiC31-int is active in many eukaryotic cells, such as murine or human cells, and directs the integration of a DNA substrate into pseudo attP sites (pattP) which are homologous to the native attP site. In this study, we combined the efficiency of NILV for gene delivery and the specificity of phiC31-int for DNA substrate integration to engineer a hybrid tool for gene transfer with the aim of allowing long term expression in dividing and non-dividing cells preventing genotoxicity. We demonstrated the feasibility to target NILV integration in human and murine pattP sites with a dual NILV vectors system: one which delivers phiC31-int, the other which constitute the substrate containing an attB site in its DNA sequence. These promising results are however alleviated by the occurrence of significant DNA damages. Further improvements are thus required to prevent chromosomal rearrangements for a therapeutic use of the system. However, its use as a tool for experimental applications such as transgenesis is already applicable. Public Library of Science 2014-06-23 /pmc/articles/PMC4067480/ /pubmed/24956106 http://dx.doi.org/10.1371/journal.pone.0099649 Text en © 2014 Grandchamp et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Grandchamp, Nicolas Altémir, Dorothée Philippe, Stéphanie Ursulet, Suzanna Pilet, Héloïse Serre, Marie-Claude Lenain, Aude Serguera, Che Mallet, Jacques Sarkis, Chamsy Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage |
title | Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage |
title_full | Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage |
title_fullStr | Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage |
title_full_unstemmed | Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage |
title_short | Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage |
title_sort | hybrid lentivirus-phic31-int-nls vector allows site-specific recombination in murine and human cells but induces dna damage |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067480/ https://www.ncbi.nlm.nih.gov/pubmed/24956106 http://dx.doi.org/10.1371/journal.pone.0099649 |
work_keys_str_mv | AT grandchampnicolas hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage AT altemirdorothee hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage AT philippestephanie hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage AT ursuletsuzanna hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage AT piletheloise hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage AT serremarieclaude hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage AT lenainaude hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage AT serguerache hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage AT malletjacques hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage AT sarkischamsy hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage |